ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
0.62
0.00
(0.00%)
Closed November 13 4:00PM
0.00
0.00
(0.00%)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.62
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
0.62
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
1,135,358
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-7.6
Revenue
-
Net Profit
-8.63M

About Ampio Pharmaceuticals Inc

Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and advancement of immunomodulatory therapies for the treatment of pain from osteoarthritis. Its lead product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoar... Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and advancement of immunomodulatory therapies for the treatment of pain from osteoarthritis. Its lead product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19 induced respiratory distress. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-

AMPE Latest News

Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation

Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation PR Newswire ENGLEWOOD, Colo., April 3, 2024 ENGLEWOOD, Colo., April 3, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc...

Ampio Announces Voluntary Delisting and SEC Deregistration

Ampio Announces Voluntary Delisting and SEC Deregistration PR Newswire ENGLEWOOD, Colo., March 25, 2024 ENGLEWOOD, Colo., March 25, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE...

Ampio Provides Update on Results from Pre-IND Enabling Studies

Ampio Provides Update on Results from Pre-IND Enabling Studies PR Newswire ENGLEWOOD, Colo., Feb. 14, 2024 ENGLEWOOD, Colo., Feb. 14, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAPYKurv Yield Premium Strategy Apple AAPL ETF
$ 26.9496
(0.00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
$ 31.69
(0.00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
$ 26.3554
(0.00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
$ 25.705
(0.00%)
0
AAAAlternative Access First Priority CLO Bond ETF
$ 25.065
(0.00%)
0
AAPYKurv Yield Premium Strategy Apple AAPL ETF
$ 26.9496
(0.00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
$ 31.69
(0.00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
$ 26.3554
(0.00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
$ 25.705
(0.00%)
0
AAAAlternative Access First Priority CLO Bond ETF
$ 25.065
(0.00%)
0
AAPYKurv Yield Premium Strategy Apple AAPL ETF
$ 26.9496
(0.00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
$ 31.69
(0.00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
$ 26.3554
(0.00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
$ 25.705
(0.00%)
0
AAAAlternative Access First Priority CLO Bond ETF
$ 25.065
(0.00%)
0

Discussion

View Full Feed
No Posts Found

Your Recent History

Delayed Upgrade Clock